Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 2, 2010, Pages 288-289

  Baltimore, David ^a   Witte, Owen N ^b   Yang, Lili ^a   Economou, James ^b   Ribas, Antoni ^b,c  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INTERLEUKIN 2;

ADOPTIVE TRANSFER; CELL EXPANSION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LETTER; LONG TERM CARE; MELANOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITRON EMISSION TOMOGRAPHY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; VACCINATION;

ADOPTIVE TRANSFER; HUMANS; MELANOMA; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77949367145     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00666.x     Document Type: Letter

References (8)

1. Johnson, L.A., Morgan, R.A., Dudley, M.E. et al. (2009). Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114, 535-546.
2. Morgan, R.A., Dudley, M.E., Wunderlich, J.R. et al. (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126-129.
3. Ribas, A. (2006). Update on immunotherapy for melanoma. J. Natl. Compr. Canc. Netw. 4, 687-694.
4. Rosenberg, S.A., Restifo, N.P., Yang, J.C., Morgan, R.A., and Dudley, M.E. (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299-308.
5. Schumacher, T.N. (2002). T-cell-receptor gene therapy. Nat. Rev. Immunol. 2, 512-519.
6. Yang, L., and Baltimore, D. (2005). Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc. Natl. Acad. Sci. U S A 102, 4518-4523.
7. Yang, L., Qin, X.F., Baltimore, D., and Van Parijs, L. (2002). Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc. Natl. Acad. Sci. U S A 99, 6204-6209.
8. Yee, C., and Greenberg, P. (2002). Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nat. Rev. Cancer 2, 409-419.